ADLM Urges Federal Action to Ensure Safe, Equitable AI in Clinical Labs
The association urges stronger regulations and data standards to keep AI safe and fair in clinical laboratories. The Association for Diagnostics & Laboratory Medicine (ADLM) is calling on Congress and federal regulators to modernize laboratory oversight as...
Most Women Still Prefer In-Clinic Cervical Cancer Screening, Study Finds
Despite FDA approval of at-home self-collection kits, 61% of women favor clinician-collected testing, signaling continued stability for traditional lab workflows. A new national study suggests that while home-based cervical cancer screening is now an option in the...
Medicare Part B Lab Spending Hits $8.4 Billion as Genetic Testing Captures 43% of Dollars
Genetic tests make up just 5% of volume but now drive 43% of Medicare Part B lab spending, according to OIG’s latest report. Medicare Part B spending on clinical laboratory testing rose to $8.4 billion in 2024, a 5% increase over the previous year, according to the...
NIH Researchers Identify Four-Marker Blood Test That May Improve Early Pancreatic Cancer Detection
Promising retrospective results raise long-term possibilities for labs, even as clinical and regulatory plans remain unclear. NIH-supported researchers have identified a new four-marker blood test that may improve the early detection of pancreatic ductal...
CDC Traveler-Based Genomic Surveillance Program Tops One Million Participants, Giving Clinical Labs Earlier Warning on Emerging Variants
The CDC’s Traveler-Based Genomic Surveillance program has surpassed one million voluntary participants, strengthening border-based genomic monitoring that helps clinical, molecular, and public health laboratories detect emerging variants—often days before they appear...
Pay Is the Pressure Point as Clinical Labs Compete for Scarce Talent
In an economy defined by inflation, burnout, and relentless staffing shortages, compensation has become the clearest fault line in healthcare hiring—and clinical laboratories are caught squarely in it. LinkedIn survey data shows salary is now the single most...
Rising Healthcare Costs May Change How Patients Use Clinical Lab Testing
A new KFF Health Tracking Poll shows healthcare costs are now the top economic worry for U.S. households—raising concerns that patients may skip screenings or shop more aggressively for lab tests, reshaping utilization and revenue patterns in 2026. Healthcare costs...
Study Identifies Reversible Epigenetic Mechanism Behind Prostate Cancer Drug Resistance
Researchers report that treatment resistance in advanced prostate cancer is driven by epigenetic lineage plasticity rather than genetic mutations, raising new possibilities for combination therapies and biomarker development in clinical laboratories. Scientists at the...
Elizabeth Holmes Seeks Clemency as Theranos Case Continues to Shape Laboratory Trust and Oversight
The Theranos case continues to resonate in the lab community, reminding professionals of the importance of validation, transparency, and accountability. Elizabeth Holmes, the former CEO of Theranos whose company became synonymous with laboratory fraud, has formally...
Funding Standoff Jeopardizes PAMA Relief as Medicare Lab Cuts Loom
Clinical laboratories face renewed Medicare payment uncertainty as a congressional funding impasse threatens to derail temporary PAMA relief, with new CLFS cuts scheduled to take effect in days unless lawmakers act. Clinical laboratories are once again facing...
HRSA Updates Cervical Cancer Screening Guidelines, Endorses HPV Self-Collection and Mandates Insurance Coverage by 2027
Federal health officials have updated cervical cancer screening guidelines to add HPV self-collection and require insurer coverage starting in 2027, a shift that could significantly impact testing volumes and workflows for clinical laboratories. In a move that could...
ADLM Guidance Urges Labs to Rethink Emergency Department Drug Testing
New recommendations highlight the limited impact of routine urine drug testing in the ED while calling on laboratories to refine test menus, expand fentanyl screening, and improve clinician education to better support trauma care, behavioral health referrals, and...
Survey: Patients Push for Predictive Lab Testing as Cost and Reimbursement Pressures Mount
Nearly 90% of patients express interest in predictive lab tests, according to a new national survey—creating new opportunities and challenges for clinical laboratories navigating consumer demand, data fragmentation, and Medicare payment cuts. A new national survey of...
AI-Designed Cancer Sensors Could Transform Early Detection—and What It Means for Clinical Labs
AI-designed molecular sensors could enable ultra-early cancer detection through simple urine tests, signaling major shifts ahead for clinical laboratories and diagnostic workflows. Artificial intelligence (AI) is beginning to reshape how cancer could be detected and...
Paxton Lawsuit Puts Epic’s Control of Pediatric Health Records Under the Microscope
Texas Attorney General Ken Paxton is challenging Epic Systems’ handling of pediatric medical records, alleging unlawful limits on parental access and raising broader questions about data control, compliance, and oversight for providers and laboratories. For clinical...
Mark Cuban Calls for Fines on Healthcare Overbilling, Raising Stakes for Labs and Insurers
Mark Cuban argues that fines for healthcare overbilling could drive accountability across the system, putting new pressure on insurers, hospitals, and clinical labs to defend pricing and billing practices. Imagine your clinical lab got fined every time it overbilled....
Measles Outbreak Grows as US Risks Losing Elimination Status
A growing measles outbreak in South Carolina, combined with rising cases nationwide, is putting renewed pressure on clinical and public health laboratories as the US risks losing its measles elimination status. A rapidly expanding measles outbreak in South Carolina is...
New RNA Entities Found in Human Microbiome Challenge Definitions of Viruses
Researchers have identified thousands of protein-free, circular RNA molecules living inside human-associated bacteria, raising new questions for microbiology labs about how life is classified. Laboratory leaders accustomed to classifying organisms as bacteria,...
AI Cancer Diagnostics Struggle with Equity, Study Finds
Accuracy gaps in pathology AI affecting nearly 30% of diagnostic tasks highlight risks for clinical decision-making and patient outcomes, according to new research. A new study is raising important questions for pathologists as artificial intelligence (AI) becomes...
Ontario Group Calls for Funding to Expand Lab Student Training Programs
Ontario medical labs face critical staffing shortages, delaying test results. MLPAO urges $6M funding for student training to expand workforce capacity. Medical laboratories across Ontario are facing persistent staffing shortages that are delaying test results and...
Researchers Integrate Genomics, Proteomics, and EHR Data to Identify Cancer Risk Proteins and Prevention Drugs
Investigators identified more than 100 proteins linked to inherited cancer risk and dozens of existing drugs that could be repurposed for cancer prevention. Researchers at Vanderbilt University Medical Center (VUMC) and the University of Calgary have developed a new...
FDA Proposes Reclassifying Oncology Companion Diagnostics, Potentially Easing Approval Path and Expanding Patient Access
The agency says shifting certain companion diagnostic tests from Class III to Class II could reduce regulatory burden, shorten review timelines, and encourage more manufacturers to enter the market. The US Food and Drug Administration (FDA) has released a proposal...
Testmate Health and Intermountain Health Partner to Expand Rapid STI Testing Access
A new partnership between Intermountain Health and Testmate Health aims to bring rapid, lab-quality STI testing out of the central lab and into underserved communities, addressing persistent gaps in diagnosis and follow-up care. Testmate Health and Intermountain...
CAP Issues New Evidence-Based Guideline to Improve Amyloidosis Diagnosis
The College of American Pathologists outlines standardized testing and typing methods aimed at reducing diagnostic variability and improving outcomes for patients with this rare but serious disease. Clinical laboratory leaders facing growing demand for precision...
ASCP 2024 Vacancy Survey Shows Laboratory Staffing Shortages Persist Despite Pandemic-Era Gains
Vacancy rates in U.S. medical laboratories have declined since COVID-19 highs, but ASCP’s latest survey finds staffing levels remain well above pre-pandemic norms as retirements accelerate and recruitment challenges deepen. The American Society for Clinical...
-
Executive War College 2026 – Audio Recordings
$599.00 -
Sale!
Executive War College 2025 – Audio Recordings
Original price was: $599.00.$399.00Current price is: $399.00. -
ON DEMAND WEBINAR: FDA’s LDT RULE: Steps to Prepare for Your FDA First Milestone Submission
$29.95 -
WEBINAR: FDA’s LDT RULE: Steps to Prepare for Your FDA First Milestone Submission
Price range: $79.95 through $249.00 -
WEBINAR: FDA’s LDT RULE: Understanding What’s Compulsory, What’s Not!
Price range: $79.95 through $249.00 -
Executive War College 2024 – Audio Recordings
$599.00 -
SPECIAL REPORT | Better CLIA Compliance: Reviewing Top Deficiencies from Accreditors and Looking to Future CLIA Reform
$129.00 -
Sale!
SPECIAL REPORT Premium Webinar: Essential Guide to Obtaining Z-Codes for Molecular and Genetic Tests
Original price was: $195.00.$79.00Current price is: $79.00. -
DARK DAILY Webinar: What Lab Leaders Need to Know: Data Security Agreements, Surprise Billing, EKRA, AKS, CURES Act, and More
$195.00 -
Audio Recording – Executive War College Presents (2021)
$499.00